【打印本页】 【下载PDF全文】 【HTML】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 2318次   下载 1646 本文二维码信息
码上扫一扫!
以Nogo蛋白及其受体为靶点促进神经再生的研究进展
朱庄臣,倪斌*,倪斌
0
(第二军医大学长征医院骨科,上海 200003;上海长征医院)
摘要:
大量基础研究表明,哺乳动物中枢神经系统(CNS)损伤后神经再生受限的主要原因是轴突生长抑制因子的存在。研究者试图通过不同的方法来中和或破坏髓鞘,清除髓鞘相关抑制分子,从而达到促进脊髓损伤后轴突再生和神经功能恢复的目的。目前,与Nogo蛋白相关的药物和基因治疗已成为CNS损伤后促进轴突再生新的有效手段,现对其研究进展作一综述。
关键词:  Nogo蛋白  中枢神经系统  神经再生
DOI:10.3724/SP.J.1008.2010.0670
投稿时间:2009-05-16修订日期:2010-04-10
基金项目:国家自然科学基金(30872612).
Targeting Nogo protein and its receptor in promoting nerve regeneration: recent progress
ZHU Zhuang-chen, NI Bin*,nibin
(Department of Orthopaedics, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China)
Abstract:
mple evidences have showed that the failure of early regeneration of the central nervous system(CNS) in adult mammals is mainly due to the growth inhibitory factor. Efforts have been made to promote neuron regeneration and neurological function recovery by damaging myelin and removing myelin-associated inhibitors. At present, the Nogo protein associated drugs and gene therapy have become a novel effective way to promote axon regeneration after CNS injury; here we reviews the recent progress on the related issues.
Key words:  Nogo protein  central nervous system  nerve regeneration